HMGB1 and frontotemporal dementia: Therefore, we measured two gold standard in vitro ICD markers, secretion of ATP and release of HMGB121, and found that FTD significantly and dose-dependently increased both extracellular ATP (Fig. 1C) and HMGB1 (Fig. 1D).